Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 7900708)

Published in Am J Clin Oncol on April 01, 1995

Authors

S R Patel1, M A Burgess, N E Papadopoulos, K A Linke, R S Benjamin

Author Affiliations

1: Department of Melanoma/Sarcoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.

Articles by these authors

Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65

Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59

Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50

Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47

Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45

Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40

Hib disease must be prevented. Med J Aust (1994) 1.39

Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust (2001) 1.38

Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34

Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am J Med Sci (1976) 1.32

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31

Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29

Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29

Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother (1972) 1.28

A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28

Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27

Doxorubicin-induced congestive heart failure in adults. Cancer (1985) 1.26

Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact? Semin Oncol (1999) 1.25

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer (1993) 1.25

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25

Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int (2009) 1.22

Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep (1977) 1.21

Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA (1988) 1.20

Homoeopathic vaccination. What does it mean? Immunisation Interest Group of the Royal Alexandra Hospital for Children. Med J Aust (1994) 1.20

Pharmacokinetics and metabolism of adriamycin in man. Clin Pharmacol Ther (1973) 1.19

Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol (1995) 1.18

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol (1994) 1.17

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol (2001) 1.17

Varicella vaccination in Australia. J Paediatr Child Health (2005) 1.17

National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clin Infect Dis (2002) 1.16

The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell (1999) 1.15

Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13

Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer (1993) 1.09

Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol (1987) 1.09

Arterial occlusion: management of giant cell tumor and aneurysmal bone cyst. AJR Am J Roentgenol (1981) 1.09

Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery (1995) 1.08

Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer (1996) 1.05

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. J Clin Oncol (1997) 1.04

Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer (1990) 1.03

Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer (2001) 1.02

Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer (2001) 1.01

Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.01

Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants. Cancer (1996) 1.00

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia. J Clin Oncol (1995) 1.00

Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother Pharmacol (1982) 1.00

Assessment of anthracycline cardiomyopathy by endomyocardial biopsy. Ultrastruct Pathol (1994) 0.99

Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Lancet (1976) 0.99

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration. J Clin Oncol (1992) 0.99

Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer. Cancer Treat Rep (1979) 0.98

Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg (1991) 0.98

Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect (2001) 0.98

Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma. Arch Pathol Lab Med (1989) 0.98

Sarcoma of the stomach: clinicopathologic study of 43 cases. J Surg Oncol (1980) 0.97

Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma. Am J Clin Oncol (1995) 0.97

Primary extraskeletal osteosarcoma--experience with chemotherapy. J Natl Cancer Inst (1995) 0.97

A phase II trial of taxol in metastatic melanoma. Cancer (1990) 0.97

Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results. Cancer (1975) 0.97

Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol (2000) 0.96

The Australian Measles Control Campaign, 1998. Bull World Health Organ (2001) 0.96

A 15-year experience with chemotherapy of patients with paraganglioma. Cancer (1995) 0.96

The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer (1982) 0.96

The cost-effectiveness of varicella vaccine programs for Australia. Vaccine (1999) 0.96

Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res (1983) 0.95

Primary soft tissue sarcoma of the breast. Curr Treat Options Oncol (2001) 0.95

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. Cancer Res (1984) 0.94

The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group. Clin Orthop Relat Res (1982) 0.94

Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg (1999) 0.93

Successful treatment of hypoglycemia using glucagon in a patient with an extrapancreatic tumor. Ann Intern Med (1990) 0.93